**Author details**

Marcos André Vannier-Santos1 \*, Ana Márcia Suarez-Fontes1 , Juliana Almeida-Silva1 , Alessandra Lifsitch Viçosa<sup>2</sup> , Sandra Aurora Chavez Perez<sup>2</sup> , Alejandro Marcel Hasslocher-Moreno3 , Gabriel Parreiras Estolano da Silveira4 , Luciana Fernandes Portela3 and Roberto Magalhães Saraiva<sup>3</sup>

1 Laboratory of Innovations on Therapies, Education and Bioproducts (LITEB), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC-FIOCRUZ), Rio de Janeiro, Brazil

2 Institute of Technology in Drugs, Oswaldo Cruz Foundation (Farmanguinhos/ FIOCRUZ), Rio de Janeiro, Brazil

3 Clinical Research Laboratory of Chagas Disease (Lapclin-Chagas), Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil

4 Pharmacodynamics Service, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil

\*Address all correspondence to: marcos.vannier@ioc.fiocruz.br; marcos.vannier@pesquisador.cnpq.br

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Translational Research on Chagas Disease: Focusing on Drug Combination and Repositioning DOI: http://dx.doi.org/10.5772/intechopen.104231*
